Nurix Therapeutics (NRIX) Long-Term Investments (2019 - 2024)
Nurix Therapeutics (NRIX) recorded Long-Term Investments of $9.47 million in fiscal Q3 2024 (quarter ended Aug 31, 2024), down 4.1% from $9.88 million a year earlier but up 1.0% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Long-Term Investments (2019 - 2024) Analysis & Trends
At the end of FY2023 (ended Nov 30, 2023), Nurix Therapeutics reported Long-Term Investments of $7.42 million, down 88.4% from FY2022.
- Annual Long-Term Investments has a four-year compound annual growth rate of 95.7% (FY2019 to FY2023).
- Across earlier fiscal years, Long-Term Investments came in at $63.88 million in FY2022 (-53.4%), $137.19 million in FY2021 (+50.9%), $90.89 million in FY2020 and $506,000 in FY2019.
- Quarterly Long-Term Investments has ranged from $506,000 in fiscal Q4 2019 to $137.19 million in fiscal Q4 2021 over the past five years.
- Peak year-over-year performance for Long-Term Investments in the last five years was growth of 197.0% in fiscal Q3 2021, against a decline of 88.4% in fiscal Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2024 | 9.47 Mn |
| May 31, 2024 | 9.38 Mn |
| Nov 30, 2023 | 7.42 Mn |
| Aug 31, 2023 | 9.88 Mn |
| May 31, 2023 | 27.46 Mn |
| Feb 28, 2023 | 48.45 Mn |
| Nov 30, 2022 | 63.88 Mn |
| Aug 31, 2022 | 69.13 Mn |
| May 31, 2022 | 51.54 Mn |
| Feb 28, 2022 | 123.69 Mn |
| Nov 30, 2021 | 137.19 Mn |
| Aug 31, 2021 | 121.48 Mn |
| May 31, 2021 | 110.44 Mn |
| Feb 28, 2021 | 77.19 Mn |
| Nov 30, 2020 | 90.89 Mn |
| Aug 31, 2020 | 40.90 Mn |
| Nov 30, 2019 | 506,000.00 |
API Access
Nurix Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();